Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 6/20 | 0.35 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6802545 | 1.00 | KCNH2 (0.35) | KCNH2SCN5AKDM4EALDH1A1HPGD | |
| SCHEMBL6802539 | 1.00 | KCNH2 (0.35) | KCNH2SCN5AKDM4EALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL6797517 | 0.90 | KCNH2 (0.41) | KCNH2SCN5AKDM4EALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL6797515 | 0.90 | KCNH2 (0.41) | KCNH2SCN5AKDM4EALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL6797521 | 0.90 | KCNH2 (0.41) | KCNH2SCN5AKDM4EALDH1A1HPGD | |
| SCHEMBL5284548 | 0.87 | KCNH2 (0.37) | KCNH2SCN5AKDM4EALDH1A1HPGD | |
| SCHEMBL5284554 | 0.87 | KCNH2 (0.37) | KCNH2SCN5AKDM4EALDH1A1HPGD | |
| SCHEMBL5570849 | 0.87 | KCNH2 (0.36) | KCNH2SCN5AKDM4EALDH1A1HPGD | |
| SCHEMBL14497297 | 0.87 | KCNH2 (0.36) | KCNH2SCN5AKDM4EALDH1A1HPGD | |
| SCHEMBL5570851 | 0.87 | KCNH2 (0.36) | KCNH2SCN5AKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040029882-A1 | Antimicrobial quinolones, their compositions and uses | THE PROCTER & GAMBLE CO. | 2004-02-12 | — | — | US | disclosed |
| US-6645981-B2 | For therapy of microbial infection | THE PROCTER & GAMBLE COMPANY | 2003-11-11 | — | — | US | disclosed |
| US-20030008894-A1 | Antimicrobial quinolones, their compositions and uses | THE PROCTER & GAMBLE COMPANY | 2003-01-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030008894-A1 | Antimicrobial quinolones, their compositions and uses | QARS1, NQO2, Q6ZSR9 | KCNH2 1547/4885SCN5A 847/4885KDM4E 4329/4885 |
| US-20040029882-A1 | Antimicrobial quinolones, their compositions and uses | QARS1, NQO2, Q6ZSR9 | KCNH2 1547/4885SCN5A 847/4885KDM4E 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.